Merck’s $6.7B Terns Acquisition Positions It to Challenge a Blockbuster Novartis Cancer Drug
Merck has been buying belongings that might assist make up for the approaching income decline as its high product, the ...
Tag: Novartis
Estate of Henrietta Lacks settles with Novartis over immortal cells
Novartis has settled a lawsuit by the property of Henrietta Lacks that alleged the pharmaceutical large unjustly profited off her ...
Novartis to acquire RNA-focused Avidity Biosciences for $12B
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — ...
With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen
Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings ...
Novartis, Regeneron, J&J, cancer research
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Viz.ai, Novartis partner for AI-powered care for patients with cancer
Viz.ai, a company involved in AI-backed imaging and care coordination, is collaborating with pharma giant Novartis to develop proprietary AI-powered ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!